Methylprednisolone Withdrawn Phase 1 Trials for Neuromyelitis Optica Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02087813Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses